[
  {
    "sentence": "Only 234 (8%) samples were identified with ASXL1 c.1934dupG with VAF≥10% (Fig 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In contrast, 5 cases with VF > 10% showed a minor sequence with ASXL1 c.1934dupG in a sub-hemyzigous fraction (Fig 1E and S1 Fig).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the case of SNPs, VAF is constant, ≈50 or ≈100% whereas for c.1934dupG; p.Gly646fs the VAF was variable in different samples from the same patient at different time-points (Fig 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Both ASXL1 c.1934dupG p.G646fs*11 and MLL/KMT2A c4737_4739dupTGA p.D1580dup remain relatively constant along time.Additional evidence for the somatic origin of ASXL1 mutation was its VAF correlation with other somatic mutations found in serial samples from the same patient (Fig 2) indicating a somatic origin in the clonal cells.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "From the molecular diagnostic standpoint, we suggest a conservative cutoff of 10% to consider a c.1934dupG mutation true when NGS experiments are performed using amplicon-based library preparation platforms, based on two observations: first, samples with a VAF ≥ 10% for ASXL1 c.1934dupG mutation were confirmed using Sanger sequencing with Phusion high/fidelity DNA polymerase (Fig 1 and S1 Fig); second, the population based scatter plot comparing VAF in every NGS experiment using amplicon-based library preparation from the clinical samples cohort in our center (Fig 1) showed a dramatic reduction in the frequency of cases with a VAF above 10.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Only 234 (8%) samples were identified with ASXL1 c.1934dupG with VAF≥10% (Fig 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In contrast, 5 cases with VF > 10% showed a minor sequence with ASXL1 c.1934dupG in a sub-hemyzigous fraction (Fig 1E and S1 Fig).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the case of SNPs, VAF is constant, ≈50 or ≈100% whereas for c.1934dupG; p.Gly646fs the VAF was variable in different samples from the same patient at different time-points (Fig 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Both ASXL1 c.1934dupG p.G646fs*11 and MLL/KMT2A c4737_4739dupTGA p.D1580dup remain relatively constant along time.Additional evidence for the somatic origin of ASXL1 mutation was its VAF correlation with other somatic mutations found in serial samples from the same patient (Fig 2) indicating a somatic origin in the clonal cells.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "From the molecular diagnostic standpoint, we suggest a conservative cutoff of 10% to consider a c.1934dupG mutation true when NGS experiments are performed using amplicon-based library preparation platforms, based on two observations: first, samples with a VAF ≥ 10% for ASXL1 c.1934dupG mutation were confirmed using Sanger sequencing with Phusion high/fidelity DNA polymerase (Fig 1 and S1 Fig); second, the population based scatter plot comparing VAF in every NGS experiment using amplicon-based library preparation from the clinical samples cohort in our center (Fig 1) showed a dramatic reduction in the frequency of cases with a VAF above 10.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Only 234 (8%) samples were identified with ASXL1 c.1934dupG with VAF≥10% (Fig 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In contrast, 5 cases with VF > 10% showed a minor sequence with ASXL1 c.1934dupG in a sub-hemyzigous fraction (Fig 1E and S1 Fig).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the case of SNPs, VAF is constant, ≈50 or ≈100% whereas for c.1934dupG; p.Gly646fs the VAF was variable in different samples from the same patient at different time-points (Fig 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Both ASXL1 c.1934dupG p.G646fs*11 and MLL/KMT2A c4737_4739dupTGA p.D1580dup remain relatively constant along time.Additional evidence for the somatic origin of ASXL1 mutation was its VAF correlation with other somatic mutations found in serial samples from the same patient (Fig 2) indicating a somatic origin in the clonal cells.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "From the molecular diagnostic standpoint, we suggest a conservative cutoff of 10% to consider a c.1934dupG mutation true when NGS experiments are performed using amplicon-based library preparation platforms, based on two observations: first, samples with a VAF ≥ 10% for ASXL1 c.1934dupG mutation were confirmed using Sanger sequencing with Phusion high/fidelity DNA polymerase (Fig 1 and S1 Fig); second, the population based scatter plot comparing VAF in every NGS experiment using amplicon-based library preparation from the clinical samples cohort in our center (Fig 1) showed a dramatic reduction in the frequency of cases with a VAF above 10.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Only 234 (8%) samples were identified with ASXL1 c.1934dupG with VAF≥10% (Fig 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In contrast, 5 cases with VF > 10% showed a minor sequence with ASXL1 c.1934dupG in a sub-hemyzigous fraction (Fig 1E and S1 Fig).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the case of SNPs, VAF is constant, ≈50 or ≈100% whereas for c.1934dupG; p.Gly646fs the VAF was variable in different samples from the same patient at different time-points (Fig 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Both ASXL1 c.1934dupG p.G646fs*11 and MLL/KMT2A c4737_4739dupTGA p.D1580dup remain relatively constant along time.Additional evidence for the somatic origin of ASXL1 mutation was its VAF correlation with other somatic mutations found in serial samples from the same patient (Fig 2) indicating a somatic origin in the clonal cells.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "From the molecular diagnostic standpoint, we suggest a conservative cutoff of 10% to consider a c.1934dupG mutation true when NGS experiments are performed using amplicon-based library preparation platforms, based on two observations: first, samples with a VAF ≥ 10% for ASXL1 c.1934dupG mutation were confirmed using Sanger sequencing with Phusion high/fidelity DNA polymerase (Fig 1 and S1 Fig); second, the population based scatter plot comparing VAF in every NGS experiment using amplicon-based library preparation from the clinical samples cohort in our center (Fig 1) showed a dramatic reduction in the frequency of cases with a VAF above 10.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Only 234 (8%) samples were identified with ASXL1 c.1934dupG with VAF≥10% (Fig 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In contrast, 5 cases with VF > 10% showed a minor sequence with ASXL1 c.1934dupG in a sub-hemyzigous fraction (Fig 1E and S1 Fig).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the case of SNPs, VAF is constant, ≈50 or ≈100% whereas for c.1934dupG; p.Gly646fs the VAF was variable in different samples from the same patient at different time-points (Fig 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Both ASXL1 c.1934dupG p.G646fs*11 and MLL/KMT2A c4737_4739dupTGA p.D1580dup remain relatively constant along time.Additional evidence for the somatic origin of ASXL1 mutation was its VAF correlation with other somatic mutations found in serial samples from the same patient (Fig 2) indicating a somatic origin in the clonal cells.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "From the molecular diagnostic standpoint, we suggest a conservative cutoff of 10% to consider a c.1934dupG mutation true when NGS experiments are performed using amplicon-based library preparation platforms, based on two observations: first, samples with a VAF ≥ 10% for ASXL1 c.1934dupG mutation were confirmed using Sanger sequencing with Phusion high/fidelity DNA polymerase (Fig 1 and S1 Fig); second, the population based scatter plot comparing VAF in every NGS experiment using amplicon-based library preparation from the clinical samples cohort in our center (Fig 1) showed a dramatic reduction in the frequency of cases with a VAF above 10.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Only 234 (8%) samples were identified with ASXL1 c.1934dupG with VAF≥10% (Fig 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In contrast, 5 cases with VF > 10% showed a minor sequence with ASXL1 c.1934dupG in a sub-hemyzigous fraction (Fig 1E and S1 Fig).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the case of SNPs, VAF is constant, ≈50 or ≈100% whereas for c.1934dupG; p.Gly646fs the VAF was variable in different samples from the same patient at different time-points (Fig 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Both ASXL1 c.1934dupG p.G646fs*11 and MLL/KMT2A c4737_4739dupTGA p.D1580dup remain relatively constant along time.Additional evidence for the somatic origin of ASXL1 mutation was its VAF correlation with other somatic mutations found in serial samples from the same patient (Fig 2) indicating a somatic origin in the clonal cells.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "From the molecular diagnostic standpoint, we suggest a conservative cutoff of 10% to consider a c.1934dupG mutation true when NGS experiments are performed using amplicon-based library preparation platforms, based on two observations: first, samples with a VAF ≥ 10% for ASXL1 c.1934dupG mutation were confirmed using Sanger sequencing with Phusion high/fidelity DNA polymerase (Fig 1 and S1 Fig); second, the population based scatter plot comparing VAF in every NGS experiment using amplicon-based library preparation from the clinical samples cohort in our center (Fig 1) showed a dramatic reduction in the frequency of cases with a VAF above 10.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Only 234 (8%) samples were identified with ASXL1 c.1934dupG with VAF≥10% (Fig 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In contrast, 5 cases with VF > 10% showed a minor sequence with ASXL1 c.1934dupG in a sub-hemyzigous fraction (Fig 1E and S1 Fig).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the case of SNPs, VAF is constant, ≈50 or ≈100% whereas for c.1934dupG; p.Gly646fs the VAF was variable in different samples from the same patient at different time-points (Fig 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Both ASXL1 c.1934dupG p.G646fs*11 and MLL/KMT2A c4737_4739dupTGA p.D1580dup remain relatively constant along time.Additional evidence for the somatic origin of ASXL1 mutation was its VAF correlation with other somatic mutations found in serial samples from the same patient (Fig 2) indicating a somatic origin in the clonal cells.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "From the molecular diagnostic standpoint, we suggest a conservative cutoff of 10% to consider a c.1934dupG mutation true when NGS experiments are performed using amplicon-based library preparation platforms, based on two observations: first, samples with a VAF ≥ 10% for ASXL1 c.1934dupG mutation were confirmed using Sanger sequencing with Phusion high/fidelity DNA polymerase (Fig 1 and S1 Fig); second, the population based scatter plot comparing VAF in every NGS experiment using amplicon-based library preparation from the clinical samples cohort in our center (Fig 1) showed a dramatic reduction in the frequency of cases with a VAF above 10.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Only 234 (8%) samples were identified with ASXL1 c.1934dupG with VAF≥10% (Fig 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In contrast, 5 cases with VF > 10% showed a minor sequence with ASXL1 c.1934dupG in a sub-hemyzigous fraction (Fig 1E and S1 Fig).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the case of SNPs, VAF is constant, ≈50 or ≈100% whereas for c.1934dupG; p.Gly646fs the VAF was variable in different samples from the same patient at different time-points (Fig 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Both ASXL1 c.1934dupG p.G646fs*11 and MLL/KMT2A c4737_4739dupTGA p.D1580dup remain relatively constant along time.Additional evidence for the somatic origin of ASXL1 mutation was its VAF correlation with other somatic mutations found in serial samples from the same patient (Fig 2) indicating a somatic origin in the clonal cells.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "From the molecular diagnostic standpoint, we suggest a conservative cutoff of 10% to consider a c.1934dupG mutation true when NGS experiments are performed using amplicon-based library preparation platforms, based on two observations: first, samples with a VAF ≥ 10% for ASXL1 c.1934dupG mutation were confirmed using Sanger sequencing with Phusion high/fidelity DNA polymerase (Fig 1 and S1 Fig); second, the population based scatter plot comparing VAF in every NGS experiment using amplicon-based library preparation from the clinical samples cohort in our center (Fig 1) showed a dramatic reduction in the frequency of cases with a VAF above 10.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Only 234 (8%) samples were identified with ASXL1 c.1934dupG with VAF≥10% (Fig 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In contrast, 5 cases with VF > 10% showed a minor sequence with ASXL1 c.1934dupG in a sub-hemyzigous fraction (Fig 1E and S1 Fig).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the case of SNPs, VAF is constant, ≈50 or ≈100% whereas for c.1934dupG; p.Gly646fs the VAF was variable in different samples from the same patient at different time-points (Fig 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Both ASXL1 c.1934dupG p.G646fs*11 and MLL/KMT2A c4737_4739dupTGA p.D1580dup remain relatively constant along time.Additional evidence for the somatic origin of ASXL1 mutation was its VAF correlation with other somatic mutations found in serial samples from the same patient (Fig 2) indicating a somatic origin in the clonal cells.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Only 234 (8%) samples were identified with ASXL1 c.1934dupG with VAF≥10% (Fig 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "Only 234 (8%) samples were identified with ASXL1 c.1934dupG with VAF≥10% (Fig 1).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In contrast, 5 cases with VF > 10% showed a minor sequence with ASXL1 c.1934dupG in a sub-hemyzigous fraction (Fig 1E and S1 Fig).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In contrast, 5 cases with VF > 10% showed a minor sequence with ASXL1 c.1934dupG in a sub-hemyzigous fraction (Fig 1E and S1 Fig).",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "Panel E",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "In the case of SNPs, VAF is constant, ≈50 or ≈100% whereas for c.1934dupG; p.Gly646fs the VAF was variable in different samples from the same patient at different time-points (Fig 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Both ASXL1 c.1934dupG p.G646fs*11 and MLL/KMT2A c4737_4739dupTGA p.D1580dup remain relatively constant along time.Additional evidence for the somatic origin of ASXL1 mutation was its VAF correlation with other somatic mutations found in serial samples from the same patient (Fig 2) indicating a somatic origin in the clonal cells.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "In the case of SNPs, VAF is constant, ≈50 or ≈100% whereas for c.1934dupG; p.Gly646fs the VAF was variable in different samples from the same patient at different time-points (Fig 2).",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "Additional evidence for the somatic origin of ASXL1 mutation was its VAF correlation with other somatic mutations found in serial samples from the same patient (Fig 2) indicating a somatic origin in the clonal cells.",
    "figure_references": [
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      },
      {
        "figure_number": "Figure 2",
        "panel": "",
        "figure_key": "figure_2"
      }
    ]
  },
  {
    "sentence": "From the molecular diagnostic standpoint, we suggest a conservative cutoff of 10% to consider a c.1934dupG mutation true when NGS experiments are performed using amplicon-based library preparation platforms, based on two observations: first, samples with a VAF ≥ 10% for ASXL1 c.1934dupG mutation were confirmed using Sanger sequencing with Phusion high/fidelity DNA polymerase (Fig 1 and S1 Fig); second, the population based scatter plot comparing VAF in every NGS experiment using amplicon-based library preparation from the clinical samples cohort in our center (Fig 1) showed a dramatic reduction in the frequency of cases with a VAF above 10.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  },
  {
    "sentence": "From the molecular diagnostic standpoint, we suggest a conservative cutoff of 10% to consider a c.1934dupG mutation true when NGS experiments are performed using amplicon-based library preparation platforms, based on two observations: first, samples with a VAF ≥ 10% for ASXL1 c.1934dupG mutation were confirmed using Sanger sequencing with Phusion high/fidelity DNA polymerase (Fig 1 and S1 Fig); second, the population based scatter plot comparing VAF in every NGS experiment using amplicon-based library preparation from the clinical samples cohort in our center (Fig 1) showed a dramatic reduction in the frequency of cases with a VAF above 10.",
    "figure_references": [
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      },
      {
        "figure_number": "Figure 1",
        "panel": "",
        "figure_key": "figure_1"
      }
    ]
  }
]